FOCIS-iSBTc Satellite Symposium
Cellular Immunology and the Immunotherapy of Cancer V

Thursday, May 15, 2003
Paris, France


Organizers:

Michael T. Lotze, MD
University of Pittsburgh, Pittsburgh, PA

Michael B. Atkins, MD
Beth Israel Deaconess Medical Center, Boston, MA

Laurence Zitvogel, MD, PhD
Institute Gustave Roussy, Cedex, France

13:00-13:05 Welcome and Introduction
Michael T. Lotze, MD
Michael B. Atkins, MD
Laurence Zitvogel, MD, PhD
13:05-13:45

Keynote Address:
The Extended IL-12 Family Members: IL-12, IL-23, and IL-27
Giorgio Trinchieri, MD - Schering-Plough Research Institute, Dardilly, France
14:00-14:30

Directed Delivery of IL-1 Family Members at the Immunological Synapse
Anna Rubartelli, MD - National Cancer Research Institute, Genova, Italy
14:30-15:00 Application of IL-1 Family Members in Cancer Therapy
Michael T. Lotze, MD - University of Pittsburgh, Pittsburgh, PA
15:00-15:30

Exosome Clinical Trials
Laurence Zitvogel, MD, PhD - Institute Gustave Roussy, Cedex, France
15:30-16:00

Measuring Immunity in Melanoma Clinical Trials
Ulrich Keilholz, MD - UKBF, Free University, Berlin, Germany
16:00-16:30

Circulating Tumor Cells in Peripheral Blood as Surrogate Efficacy Marker for Cancer Immunotherapies
Hans Loibner, PhD - Igeneon AG, Vienna, Austria
16:30-17:00

Tumor Vaccines: Which Adjuvant?
Vincent Brichard, MD, PhD - GlaxoSmithKline Biologicals, Rixensart, Belgium
17:00-17:30

Tetramer Analysis of Class I and Class II Reactive T-Cells
Markus J. Maeurer, MD - University of Mainz, Mainz, Germany
17:30-18:00 Application of IL-2 and other Cytokines in Renal Cancer
 Michael B. Atkins, MD - Beth Israel Deaconess Medical Center, Boston, MA